Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2023 11:57 ET | Source: Robbins LLP

Y-mAbs Therapeutics, Inc. (YMAB) Class Action Notice: Robbins LLP Urges Shareholders to Contact the Firm for Information Regarding Their Rights

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
February 09, 2023 15:04 ET | Source: Robbins LLP

Y-mAbs Therapeutics, Inc. (YMAB) Class Action Notice: Robbins LLP Urges Shareholders to Contact the Firm for Information Regarding Their Rights

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
February 02, 2023 15:23 ET | Source: Robbins LLP

Y-mAbs Therapeutics, Inc. (YMAB) Investor Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against Y-mAbs Therapeutics, Inc.

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...
January 24, 2023 14:31 ET | Source: Robbins LLP

Y-mAbs Therapeutics, Inc. (YMAB) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Y-mAbs Therapeutics, Inc.

SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased shares of Y-mAbs...